Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty Corporation on July 14, 2026, paying $39.00 per share in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions